Home Cart Sign in  
Chemical Structure| 446-72-0 Chemical Structure| 446-72-0

Structure of Genistein
CAS No.: 446-72-0

Chemical Structure| 446-72-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Genistein has multiple biological functions. It can inhibit several tyrosine kinases (IC50 of 0.6 μM for EGFR), inhibits DNA topoisomerase-II and activation of PPARs. Genistein is a phytoestrogen which has selective estrogen receptor modulator properties.

Synonyms: NPI 031L; CI-75610; BIO300

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Genistein

CAS No. :446-72-0
Formula : C15H10O5
M.W : 270.24
SMILES Code : O=C1C(C2=CC=C(O)C=C2)=COC3=C1C(O)=CC(O)=C3
Synonyms :
NPI 031L; CI-75610; BIO300
MDL No. :MFCD00016952
InChI Key :TZBJGXHYKVUXJN-UHFFFAOYSA-N
Pubchem ID :5280961

Safety of Genistein

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Genistein

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • EGFR/ErbB1

  • Topo II

In Vitro:

Cell Line
Concentration Treated Time Description References
Xenopus oocytes 10.7 µM 6 minutes To study the inhibitory effect of Genistein on hK2P3.1 currents Br J Pharmacol. 2008 Aug;154(8):1680-90
CHO cells 12.3 µM 3-4 minutes To study the inhibitory effect of Genistein on hK2P3.1 currents Br J Pharmacol. 2008 Aug;154(8):1680-90
porcine sino-atrial node cells 200 μM To investigate the effect of Genistin on the hyperpolarization-activated cation current (If), results showed no significant effect of Genistin on If. Br J Pharmacol. 1999 Nov;128(6):1284-90

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00355953 Menopause|Osteopenia PHASE2|PHASE3 COMPLETED 2025-06-05 -
NCT06501768 Heart Failure PHASE1|PHASE2 RECRUITING 2026-09-01 UMC Ljubljana, Ljubljana, 1000... More >>, Slovenia Less <<
NCT00001696 Cancer PHASE1 COMPLETED 2025-03-01 National Cancer Institute (NCI... More >>), Bethesda, Maryland, 20892, United States Less <<
NCT06634108 Amyloid Cardiomyopathy PHASE1|PHASE2 RECRUITING 2025-05-01 London Regional Health Science... More >> Centre, London, Ontario, N6A 5A5, Canada Less <<
NCT01985763 Colon Cancer|Rectal Cancer|Col... More >>orectal Cancer Less << PHASE1|PHASE2 COMPLETED 2018-10-31 Icahn School of Medicine at Mo... More >>unt Sinai, New York, New York, 10029, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.70mL

0.74mL

0.37mL

18.50mL

3.70mL

1.85mL

37.00mL

7.40mL

3.70mL

References

 

Historical Records

Categories